A new study shows that Tirzepatide, sold as Mounjaro and Zepbound, could trigger the body's calorie-burning brown fat in obese mice. This suggests a potential metabolic effect beyond appetite suppression, which could lead to better understanding of the drug's benefits and development of more effective treatments for obesity and diabetes.
מקור: Latest Science News — ScienceDaily — לכתבה המלאה
כתיבת תגובה